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S U M M A R Y
Objectives: The present study was designed to determine the genotypes of circulating Bordetella pertussis
in the Philippines by direct molecular typing of clinical specimens.
Methods: Nasopharyngeal swabs (NPSs) were collected from 50 children hospitalized with pertussis in
three hospitals during 2012–2014. Multilocus variable-number tandem repeat analysis (MLVA) was
performed on the DNA extracts from NPSs. B. pertussis virulence-associated allelic genes (ptxA, prn, and
ﬁm3) and the pertussis toxin promoter, ptxP, were also investigated by DNA sequence-based typing.
Results: Twenty-six DNA extracts yielded a complete MLVA proﬁle, which were sorted into 10 MLVA
types. MLVA type 34 (MT34), which is rare in Australia, Europe, Japan, and the USA, was the predominant
strain (50%). Seven MTs (MT29, MT32, MT33, and MT283–286, total 42%) were single-locus variants of
MT34, while two (MT141 and MT287, total 8%) were double-locus variants of MT34. All MTs had the
combination of virulence-associated allelic genes, ptxP1–ptxA1–prn1–ﬁm3A.
Conclusions: The B. pertussis population in the Philippines comprises genetically related strains. These
strains are markedly different from those found in patients from other countries where acellular
pertussis vaccines are used. The differences in vaccine types between these other countries and the
Philippines, where the whole-cell vaccine is still used, may select for distinct populations of B. pertussis.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Bordetella pertussis, a highly communicable Gram-negative
coccobacillus, is the etiological agent of whooping cough (pertussis),
a major acute respiratory infection resulting in severe childhood
illness and infant death. In the Philippines, pertussis is controlled by
the administration of the whole-cell pertussis vaccine (WCV),
given in three doses at ages 6, 10, and 14 months. The pentavalent
DTwP-HepB-Hib vaccine (diphtheria, tetanus toxoids, whole-cell
pertussis, hepatitis B, Haemophilus inﬂuenzae type b), Easyﬁve-TT
(Panacea Biotec Ltd, India), is the most common vaccine currently
used for immunization. Despite these controls, pertussis* Corresponding author. Tel.: +81-42-848-7101; fax: +81-42-561-7173.
E-mail address: kamachi@nih.go.jp (K. Kamachi).
http://dx.doi.org/10.1016/j.ijid.2015.04.001
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).infections have occurred sporadically, primarily in unvaccinated
children (<6 months of age). The molecular epidemiology of
B. pertussis populations has been studied in several countries,1–5
but no information of the speciﬁc strains present in the
Philippines has been reported. Molecular typing of the organism
can be performed on both bacterial isolates and clinical speci-
mens.6 The genotypes of the circulating strains of B. pertussis in
the Philippines were therefore determined by direct molecular
typing of clinical specimens.
2. Materials and methods
Between September 2012 and May 2014, 50 children hospital-
ized with severe respiratory distress (median age 2 months, range
053 months) were diagnosed with B. pertussis infections by PCR
targeting IS481.7 Patients were hospitalized at the Philippineciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. Minimum spanning tree revealing the genetic diversity of the Bordetella
pertussis population in the Philippines during 2012–2014. MLVA types (MTs) were
identiﬁed from DNA extracts of clinical specimens, collected from 26 patients. Each
circle within a tree represents a unique MT, and the number denotes the MT. The
sizes of circles are representative of the number of clinical specimens in each group,
with the numbers indicated in parentheses. Lines connecting circles represent
single-locus variants. All MTs carried ptxP1, ptxA1, prn1, and ﬁm3A alleles. PGH,
Philippine General Hospital; ONP, Ospital ng Palawan; RITM, Research Institute for
Tropical Medicine.
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17 patients), and the Research Institute for Tropical Medicine
(RITM; seven patients) (Supplementary Material, Figure S1).
Nasopharyngeal swabs (NPSs) were obtained from the patients,
and DNA was extracted from the NPSs using the QIAamp DNA Mini
Kit (Qiagen).
Multilocus variable-number tandem repeat analysis (MLVA)
typing was performed on DNA extracted from NPSs.6 MLVA types
(MTs) were assigned using the MLVA typing tool found at http://
www.mlva.net. Novel MTs were assigned by Ing. H. van der Heide,
National Institute for Public Health and the Environment, the
Netherlands. To characterize the phylogenic relationships between
the MTs, minimum spanning trees were generated using FPQuest
software (Bio-Rad). DNA sequence-based typing for B. pertussis
virulence-associated allelic genes (ptxA, prn, and ﬁm3) and the
pertussis toxin promoter, ptxP, was performed on DNA extracts
that yielded a complete six-allele MLVA proﬁle, with some
modiﬁcations.5 Brieﬂy, PCR cycling conditions were 94 8C for
2 min, followed by 11 cycles of touchdown PCR (98 8C for 10 s,
followed by annealing, initially at 65 8C for 30 s and decreasing
1 8C/cycle until 55 8C, and elongation at 68 8C for 45 s) and
25 cycles of standard PCR (98 8C for 10 s, 55 8C for 30 s, and 68 8C for
45 s). For ptxP and variable region 2 (R2) of prn, some DNA extracts
that failed to yield DNA sequences were analyzed by nested PCR.
The PCR primer sets used in this study are listed in the
Supplementary Material (Table S1).
3. Results
DNA extracts from NPSs were collected from 50 patients and
analyzed by MLVA typing. Twenty-six (52%) samples yielded a
complete six-allele MLVA proﬁle, and the remainder yielded either
a partial proﬁle (38%) or a negative MLVA result (10%) (Table 1).
The complete MLVA proﬁles were obtained primarily from patients
aged between 1 and <3 months; however, distributions of patient
age among the three MLVA groups (complete proﬁles, partial
proﬁles, no alleles) were not signiﬁcantly different (p = 0.87,
Fisher’s exact test). The MLVA results therefore did not depend on
patient age.
Among the 26 DNA extracts that yielded a complete MLVA
proﬁle, 10 distinct MTs were identiﬁed, of which ﬁve were novel:
MT283, MT284, MT285, MT286, and MT287. Figure 1 shows a
minimum spanning tree that revealed the genetic diversity of the
B. pertussis population. MT34 was the most prevalent type (n = 13)
and MT33 was the second most prevalent (n = 4). Eight MTs (MT29,
MT32, MT141, MT283, and MT284–287) were minor subtypes,
appearing only rarely (n = 1 or 2). All MTs had a combination of
ptxP1–ptxA1–prn1–ﬁm3A alleles, as demonstrated by DNA
sequence-based typing. The MT distribution was not statisticallyTable 1
Summary of MLVA results for 50 pertussis patients grouped by age
Patient age range Number of clinical
specimens
MLVA resulta
Complete
proﬁle
Partial
proﬁle
0 to <1 month 2 1 1 
1 to <2 months 21 11 8 
2 to <3 months 14 8 5 
3 to <12 months 8 4 3 
1 to 4 years 4 2 2 
Unknown 1c
Total 50 26 19 
MLVA, multilocus variable-number tandem repeat analysis.
a Complete proﬁle, six alleles; partial proﬁle, from one to ﬁve alleles.
b MLVA types were determined using the complete proﬁle.
c Patient age was <2 months.different among the three hospitals, PGH, ONP, and RITM (p = 0.23,
Fisher’s exact test).
4. Discussion
In this study, the B. pertussis MT34 strain was demonstrated to
be the predominant (50%) subtype in the Philippines during 2012–
2014. Seven MTs (MT29, MT32, MT33, and MT283–286, total 42%)
were single-locus variants of MT34, and two others (MT141 and
MT287, total 8%) were double-locus variants of MT34. All MT
strains carried the same virulence-associated allelic genes, ptxP1–
ptxA1–prn1–ﬁm3A. These data suggest that the B. pertussis
population in the Philippines comprises genetically related strains.
In Australia, Europe, and the USA, the B. pertussis MT27 strain
(double-locus variant of MT34) was the predominant type during
the past decade.2–4,6,8,9 In Japan, both MT27 and MT186 were the
predominant types during 2002–2012, with only one MT34 strain
found out of 134 B. pertussis isolates tested.5 The Japanese MT34
strain carried the same virulence-associated genes, ptxP1–ptxA1–
prn1–ﬁm3A, as the MT34 strain from the Philippines described in
this study. MT34 strains have been identiﬁed very rarely
throughout the world.1–4,10 In Australia, the USA, Japan, and mostMLVA typeb
No alleles
generated
MT286
2 MT29, MT32, MT34, MT141, MT284, MT285, MT287
1 MT33, MT34, MT284
1 MT33, MT34
MT34, MT283
1
5
S.R.L. Galit et al. / International Journal of Infectious Diseases 35 (2015) 24–2626European countries, acellular pertussis vaccines (ACVs) have been
used, whereas a WCV is still used in the Philippines. Thus, the
different vaccine types may select for different B. pertussis
populations.
This study provides a baseline for future studies on the
B. pertussis population in the Philippines.
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